IMMUTIL 500MG TABLET

Immutil 500 mg tablet is an immunosuppressant with an active ingredient, Mycophenolate mofetil. It is part of the inosine-monophosphate dehydrogenase (IMPDH) inhibitor class. It is used to stop the rejection of organs in patients who have received one of their organs (such as heart, kidney, or liver transplantation). It is usually prescribed as a part of a combination treatment, which includes other immunosuppressive medications.
This medication is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. It is not recommended during pregnancy unless there are no other alternatives and the possible benefits outweigh any risks. Women who are born are strongly advised to make use of effective contraception while taking this tablet to avoid pregnancies. Live vaccines shouldn’t be administered while a patient takes an Immutil 500 mg tablet due to the vaccine’s lower effectiveness and the possibility of contracting it. People taking this drug must not give blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is eliminated from the body before blood is donated.
It is recommended not to use this medication when allergic to the drug or other ingredients. Inform your doctor about heart or liver disease before starting the treatment. Since this medication weakens the body’s immune system, it increases the risk of developing skin cancer. People should take steps to reduce their exposure to the ultraviolet (UV) radiation. Consult your physician immediately in the event of swelling of surface swelling, fever, unprovoked tiredness, dizziness or redness of the eyes, vision impairment, decreased urine output, or seizures following this medication. Immutil 500 mg tablet is an anti-inflammatory medication. It can affect a baby’s developing immune system and should not be used when breastfeeding. In some instances, alternative medicines with an improved safety profile when breastfeeding could be thought of as.